Lilly’s Alzheimer’s super drug to be approved ‘any day’
WELLINGTON: The pharma giant behind breakthrough Alzheimer’s drug Donanemab expects approval to come from US…
FEATURED
Trial now set to target the ‘cognitively at risk’
Surge in number of older workers staying in the workforce
Seniors housing to be woven into regeneration suburban rejig
Building design focused around an elderly-friendly future
Senior housing facility finally receives planning authorities approval
Planners approve 63 new city region homes for elderly
INNOVATION
